Status:

UNKNOWN

Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

Lead Sponsor:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions:

Hemophilia A

Eligibility:

All Genders

12-65 years

Phase:

PHASE1

Brief Summary

This is a multi-center, open-label, randomized study. Participants will be assigned to A or B groups with a scale of 1:1 , i.e. infuse study drug followed by Xyntha (group A), or the alternate sequenc...

Eligibility Criteria

Inclusion

  • Hemophilia A.
  • FVIII:C \<1%. 3)12 and 65 years old.
  • 4)Has received FVIII treatment and the treatment exposure days ≥100. 5)Has bleeding treatment records of at least 3 months before randomization. 6)FVIII inhibitor assay results is negative.
  • 7) Subjects should agree to use an adequate method of contraception during the study.
  • 8)Understood and Signed an informed consent form. 9)Has not received an treatment of any FVIII within 4 days before the first dose.
  • 10)Non-bleeding state.

Exclusion

  • Has a history or family history of blood coagulation factor VIII inhibitor.
  • Has other coagulation dysfunction diseases in addition to hemophilia A.
  • HIV positive.
  • Plan to receive surgery during the trial.
  • Has used immunomodulator within one weeks before the first dose,and less than 7 half-life periods.
  • Known to be allergic to experimental drugs or any excipients.
  • Severe anemia and need blood transfusion.
  • Serious liver or kidney damage.
  • Serious heart disease.
  • Uncontrollable hypertension.
  • Has participated in other clinical studies within one month before the first dose.
  • The researchers believe that it is not suitable for participants.

Key Trial Info

Start Date :

May 8 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2020

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04060836

Start Date

May 8 2019

End Date

March 1 2020

Last Update

August 19 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

AnHui Provincial Hospital

Hefei, Anhui, China, 230001

2

The First Hospital of LanZhou University

Lanzhou, Gansu, China, 730000

3

HeNan Cancer Provincial Hospital

Zhengzhou, Henan, China, 450008

4

Xiangya Hospital Central South University

Changsha, Hunan, China, 410013